Labcorp Investor Day: 5-8% Revenue CAGR, 8.5-11.5% EPS CAGR Through 2029
LH sits 26% above its 52-week low of $244.52 on elevated volume (1.8× avg).
Summary
Labcorp's Investor Day presentation lays out long-term targets through 2029: 5-8% revenue CAGR, 8.5-11.5% adjusted EPS CAGR, and 75-150 bps margin expansion, while reaffirming 2026 guidance.
Key Events · Earnings and Guidance · LH
-
Long-Term Outlook Through 2029
Company targets 5-8% compound annual revenue growth and 8.5-11.5% adjusted EPS CAGR through 2029, with 75-150 bps of adjusted operating margin expansion by end of 2029.
-
2026 Guidance Reaffirmed
Full-year 2026 guidance unchanged from July 30: adjusted EPS of $18.10-$18.55 and revenue of $14.71B-$14.83B, with free cash flow of $1.24B-$1.36B.
-
Capital Deployment Framework
2027-2029 illustrative plan: $6.3B-$7.2B operating cash flow, CapEx ~4% of revenue, M&A driving 1.5-2.5% revenue CAGR, dividends at 15-20% of adjusted earnings, and share repurchases covering dilution at a minimum.
-
Segment Growth Targets
Diagnostics expected to grow 2.5-4.5% CAGR, Biopharma Laboratory Services 4.0-7.0% CAGR, and organic revenue 3.5-5.5% CAGR through 2029.
Analysis · LH · Industrial Applications And Services
Labcorp's 2026 Investor Day formalizes long-term financial targets through 2029: 5-8% compound annual revenue growth, 8.5-11.5% adjusted EPS growth, and 75-150 basis points of margin expansion. The presentation adds material new detail on capital deployment — $6.3B-$7.2B in operating cash flow from 2027-2029, with M&A expected to contribute 1.5-2.5% of revenue CAGR and dividends targeted at 15-20% of adjusted earnings. The company also reaffirmed full-year 2026 guidance of $18.10-$18.55 adjusted EPS and $14.71B-$14.83B revenue, unchanged from July 30. For a $24.9B market-cap company, the long-term framework provides investors a concrete roadmap for how management plans to convert growth into shareholder returns.
How filings like this one have moved
In the 30 days to Oct 17, 2026, 29.7% of the 1531 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LH was trading at $306.96 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $24.9B. The 52-week trading range was $244.52 to $341.80. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.